Acetylsalicylic acid therapy in patients undergoing planned surgery

Cover Page

Cite item

Full Text

Abstract

In a review, we described risks and benefits of surgery performed while continuing aspirin therapy in perioperative period. Aspirin therapy is associated with mild increase in surgery related bleeding risk. On the other hand, aspirin therapy leads to significant decrease of mortality and perioperative cardiovascular risk in most cases.

About the authors

S. S Altarev

Research Institute for Complex Issues of Cardiovascular Diseases

Email: altarev@inbox.ru
канд. мед. наук, ст. науч. сотр. лаб. реабилитации отд. мультифокального атеросклероза ФГБНУ НИИ КПССЗ 650002, Russian Federation, Kemerovo, Sosnovyi b-r, d. 6

O. L Barbarash

Research Institute for Complex Issues of Cardiovascular Diseases

Email: olb61@mail.ru
д-р мед. наук, проф., дир. ФГБНУ НИИ КПССЗ 650002, Russian Federation, Kemerovo, Sosnovyi b-r, d. 6

References

  1. Roffi M, Patrono C, Collet J-P et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. EHJ 2015. doi: 10.1093/eurheartj/ehv320
  2. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
  3. Mangano D.T. Perioperative cardiovascular morbidity: new developments. Best Pract Res Clin Anaesthesiol 1999; 13 (3): 335-48.
  4. Vicenzi M.N, Meislitzer T, Heitzinger B et al. Coronary artery stenting and non - cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96: 686-93.
  5. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug - eluting stents. J Am Med Assoc 2005; 293: 2126-30.
  6. Patrono C, Baigent C, Hirsh J et al. Аntiplatelet Drugs. Chest 2008; 133 (6 Suppl.): 199S-233S.
  7. Awtry E.H, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-18.
  8. Jimenez A.H, Stubbs M.E, Tofler G.H et al. Rapidity and duration of platelet suppression by entericcoated aspirin in healthy young men. Am J Cardiol 1992; 69: 258-62.
  9. Antithrombotic Trialists’ Collaboration. Collaborative meta - analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
  10. Hall R, Mazer C.D. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011; 112: 292-318.
  11. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration. BMJ 1994; 308: 81-106.
  12. Baigent C, Blackwell L, Collins R et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta - analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-60.
  13. Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). EHJ 2012; 33: 1635-701.
  14. Amsterdam E.A, Wenger N.K, Brindis R.G et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes. Circulation 2014; 130: e344-e426.
  15. O’Gara P.T, Kushner F.G, Ascheim D.D et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation 2013; 127: e362-e425.
  16. Fihn S.D, Gardin J.M, Abrams J et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. JACC 2012; 60 (24): e44-e164.
  17. Brott T.G, Halperin J.L, Abbara S et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. Circulation 2011; 124: e54-e130.
  18. Rooke T.W, Hirsch A.T, Misra S et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline). Circulation 2011; 124: 2020-45.
  19. Burger W, Chemnitius J.M, Kneissl G.D et al. Low - dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta - analysis. J Intern Med 2005; 257: 399-414.
  20. Palmer J.D, Sparrow O.C, Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35: 1061-4.
  21. Oscarsson A, Gupta A, Fredrikson M et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104: 305-12.
  22. Kaluza G.L, Joseph J, Lee J.R et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. JACC 2000; 35: 1288-94.
  23. Sharma A.K, Ajani A.E, Hamwi S.M et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004; 63: 141-5.
  24. Biondi-Zoccai G.G, Lotrionte M, Agostoni P et al. A systematic review and meta - analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. EHJ 2006; 27: 2667-74.
  25. Collet J.P, Himbert F, Steg P.G. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000; 76: 257-8.
  26. Collet J.P, Montalescot G, Balnchet B et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7.
  27. Ferrari E, Benhamou M, Cerboni P et al. Coronary syndromes following aspirin withdrawal, a special risk for late stent thrombosis. JACC 2005; 45: 456-9.
  28. Maulaz A.B, Bezerra D.C, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62 (8): 1217-20.
  29. Sung J.J, Lau J.Y, Ching J.Y et al. Continuation of low - dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010; 152: 1-9.
  30. Madan G.A, Madan S.G, Madan G et al. Minor oral surgery without stopping daily low - dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg 2005; 63: 1262-5.
  31. Chu M.B, Turner R.B, Kriegel D.A. Patients with drug - eluting stents and management of their anticoagulant therapy in cutaneous surgery. J Am Acad Dermatol 2011; 64: 553-8.
  32. Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg 2004; 30: 1091-4.
  33. Cook-Norris R.H, Michaels J.D, Weaver A.L et al. Complications of cutaneous surgery in patients taking clopidogrel - containing anticoagulation. J Am Acad Dermatol 2011; 65: 584-91.
  34. Douketis J.D, Spyropoulos A.C, Spencer F.A et al. Perioperative Management of Antithrombotic Therapy. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141 (2 Suppl.): e326S-e350S.
  35. Manocha D, Singh M, Mehta N et al. Bleeding Risk after Invasive Procedures in Aspirin/NSAID Users: Polypectomy Study in Veterans. Am J Med 2012; 125: 1222-7.
  36. Yousfi M, Gostout C.J, Baron T.H et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004; 99: 1785-9.
  37. Hui A.J, Wong R.M, Ching J.Y et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004; 59: 44-8.
  38. Anderson M.A, Ben-Menachem T, Gan S.I et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009; 70: 1060-70.
  39. Lindblad B, Persson N.H, Takolander R et al. Does low - dose acetylsalicylic acid prevent stroke after carotid surgery? A double blind, placebo - controlled randomized trial. Stroke 1993; 24: 1125-8.
  40. Neilipovitz D.T, Bryson G.L, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93: 573-80.
  41. Rosenbaum A, Rizvi A.Z, Alden P.B et al. Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy. Ann Vasc Surg 2011; 25: 25-31.
  42. Burdess A, Nimmo A.F, Garden O.J et al. Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg 2010; 252: 37-42.
  43. Eng M, Brock G, Li X et al. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? Clin Transplant 2011; 25: 292-6.
  44. Giannarini G, Mogorovich A, Valent F et al. Continuing or discontinuing low - dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology 2007; 70: 501-5.
  45. Halliwell O.T, Yadegafar G, Lane C et al. Transrectal ultrasound - guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications. Clin Radiol 2008; 63: 557-61.
  46. Thurston A.V, Briant S.L. Aspirin and post - prostatectomy haemorrhage. Br J Urol 1993; 71: 574-6.
  47. Wierod F.S, Frandsen N.J, Jacobsen J.D et al. Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998; 32: 120-2.
  48. Nielsen J.D, Holm-Nielsen A, Jespersen J et al. The effect of low - dose acetylsalicylic acid on bleeding after transurethral prostatectomy - a prospective, randomized, double - blind, placebo - controlled study. Scand J Urol Nephrol 2000; 34: 194-8.
  49. Ala-Opas M.Y, Gronlund S.S. Blood loss in long - term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1996; 30: 203-6.
  50. Ferraris V.A, Swanson E. Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 1983; 156: 439-42.
  51. Ott M.M, Eriksson E, Vanderkolk W et al. Antiplatelet and anticoagulation therapies do not increase mortality in the absence of traumatic brain injury. J Trauma 2010; 68: 560-3.
  52. Manning B.J, O’Brien N, Aravindan S et al. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 2004; 35: 121-4.
  53. Anekstein Y, Tamir E, Halperin N et al. Aspirin therapy and bleeding during proximal femoral fracture surgery. Clin Orthop Relat Res 2004; 418: 205-8.
  54. Edmunds I, Avakian Z. Hand surgery on anticoagulated patients: a prospective study of 121 operations. Hand Surg 2010; 15: 109-13.
  55. Devereaux P.J, Mrkobrada M, Sessler D.I et al. Aspirin in Patients Undergoing Noncardiac Surgery. N Engl J Med 2014; 370 (16): 1494-503.
  56. Fleisher L.A, Fleischmann K.E, Auerbach A.D et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary. Circulation 2014; 130: 2215-45.
  57. Ghaffarinejad M.H, Fazelifar A.F, Shirvani S.M et al. The effect of preoperative aspirin use on postoperative bleeding and perioperative myocardial infarction in patients undergoing coronary artery bypass surgery. Cardiol J 2007; 14: 453-7.
  58. Srinivasan A.K, Grayson A.D, Pullan D.M et al. Effect of preoperative aspirin use in off - pump coronary artery bypass operations. Ann Thorac Surg 2003; 76: 41-5.
  59. Sun J.C, Crowther M.A, Warkentin T.E et al. Should aspirin be discontinued before coronary artery bypass surgery? Circulation 2005; 112: e85-e90.
  60. Preisman S, Kogan A, Itzkovsky K et al. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 2010; 37: 1367-74.
  61. Gulbins H, Malkoc A, Ennker I.C et al. Preoperative Platelet Inhibition with ASA Does Not Influence Postoperative Blood Loss Following Coronary Artery Bypass Grafting. Thorac Cardiovasc Surg 2009; 57 (1): 18-21.
  62. Bybee K.A, Powell B.D, Valeti U et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005; 112 (Suppl. 1): I-286-I-292.
  63. Bélisle S, Hardy J.F. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 1996; 62: 1908-17.
  64. Vuylsteke A, Oduro A, Cardan E et al. Effects of aspirin in coronary artery bypass grafting. J Cardiothorac Vasc Anaesth 1997; 11: 831-4.
  65. Sun J.C.J, Whitlock R, Cheng J et al. The effect of pre - operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 2008; 29: 1057-71.
  66. Hillis D.L, Smith P.K, Anderson J.L et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Circulation 2011; 124: e652-e735.
  67. Weil J, Colin-Jones D, Langman M et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-30.
  68. Chan F.K, Ching J.Y, Hung L.C et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005; 352: 238-44.
  69. Weisman S.M, Graham D.Y. Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events. Arch Intern Med 2002; 162: 2197-202.
  70. Savon J.J, Allen M.L, Di Marino A.J.Jr et al. Gastrointestinal blood loss with low dose (325 mg) plain and enteric - coated aspirin administration. Am J Gastroenterol 1995; 90: 581-5.
  71. Dammann H.G, Burkhardt F, Wolf N. Enteric coating of aspirin signifcantly decreases gastroduodenal mucosal lesions Aliment. Pharmacol Ther 1999; 13 (8): 1109-14.
  72. Walker J, Robinson J, Stewart J et al. Does enteric - coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Surg 2007; 6: 519-22.
  73. Моисеев В.С. Польза и риск антитромботических средств в профилактике сердечно - сосудистых заболеваний. Клин. фармакология и терапия. 2008; 17 (3): 19-24.
  74. Endo H, Sakai E, Higurashi T et al. Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy. Dig Liver Dis 2012; 44 (10): 833-8.
  75. Баркаган З.С., Момот А.П., Котовщикова Е.Ф. и др. Выбор препаратов и мониторинг эффективности антитромботических средств. В кн.: Острый коронарный синдром: проблемы патогенеза, диагностики, классификации, терапии. Томск, 2001; с. 192-4.
  76. Cox D, Maree A.O, Dooley M et al. Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy Volunteers. Stroke 2006; 37: 2153-8.
  77. Maree A.O, Curtin R.J, Dooley M et al. Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease. JACC 2005; 47: 1258-63.
  78. Grosser T, Fries S, Lawson J.A. Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin. Circulation 2013; 127 (3): 377-85.
  79. Bode-Böger S.M, Böger R.H, Schubert M et al. Effects of very low dose and enteric - coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects. Eur J Clin Pharmacol 1998; 54 (9-10): 707-14.
  80. Van Hecken A, Juliano M.L, Depré M et al. Effects of enteric - coated, low - dose aspirin on parameters of platelet function. Aliment Pharmacol Ther 2002; 16: 1683-8.
  81. ISIS-2 (Second International Study Of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 332 (8607): 349-60.
  82. Аверков О.В. Ацетилсалициловая кислота как антитромбоцитарное средство: какие лекарственные формы препарата предпочтительны с позиций доказательной медицины? Кардиоваск. терапия и профилактика. 2010; 9 (2): 61-8.
  83. Jacobs E.J, Thun M.J, Bain E.B et al. A large cohort study of long - term daily use of adult - strength aspirin and cancer incidence. J Natl Cancer Inst 2007; 99: 608-15.
  84. Ishikawa H, Mutoh M, Suzuki S et al. The preventive effects of low - dose enteric - coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut 2014; 63 (11): 1755-9.

Copyright (c) 2015 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies